Electromed, Inc.
ELMDNYSE
$42.10
↓ -1.6%Jul 17 close · end-of-day
Price
1Y↑ +128.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$364.1M
Enterprise Value
$347.1M
P/E
35.7
P/S
5.1
P/B
7.4
EV/EBITDA
24.6
PEG
0.7
FCF Yield
2.6%
Dividend Yield
—
Revenue (TTM)
$71.8M
Net Income (TTM)
$10.1M
Free Cash Flow (TTM)
$9.4M
Gross Margin
78.4%
Operating Margin
18.3%
Net Margin
14.1%
ROE
20.5%
ROIC
30.3%
Debt / Equity
—
Net Cash
$17.0M
Return 1Y
+125.7%
Company profile
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products. The company applies high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. It also provides single patient use SmartVest products for health care providers in the acute care setting.
- CEO
- Kathleen S. Skarvan
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 160
- Headquarters
- Minnesota
- Website
- smartvest.com
Management & directors
- Nagel Bradley M.Chief Financial Officer
- Cunniff James L.CEO and President
Roles derived from SEC Form 4 filings.
Earnings
ELMD Q3 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$18.6M↑ +18.4%
Diluted EPS$0.35↑ +66.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $35.8M | $41.7M | $48.1M | $54.7M | $64.0M |
| Gross profit | $27.3M | $31.4M | $36.5M | $41.7M | $50.0M |
| Operating income | $3.1M | $3.0M | $4.0M | $6.6M | $9.7M |
| Net income | $2.4M | $2.3M | $3.2M | $5.2M | $7.5M |
| Diluted EPS | $0.27 | $0.26 | $0.36 | $0.58 | $0.85 |
| Operating cash flow | $3.1M | -$686,000.00 | $1.3M | $9.1M | $11.4M |
| Free cash flow | $2.8M | -$2.1M | -$333,000.00 | $8.8M | $11.1M |
| Gross margin | 76.4% | 75.5% | 76.0% | 76.3% | 78.1% |
| Operating margin | 8.8% | 7.1% | 8.3% | 12.0% | 15.1% |
| Net margin | 6.6% | 5.5% | 6.6% | 9.4% | 11.8% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.8M | $14.7M | $16.3M | $15.7M | $17.4M | $16.9M | $18.9M | $18.6M |
| Gross profit | $11.3M | $11.5M | $12.6M | $12.2M | $13.6M | $13.2M | $14.8M | $14.6M |
| Operating income | $2.3M | $1.9M | $2.5M | $2.1M | $3.0M | $2.7M | $3.6M | $3.8M |
| Net income | $1.8M | $1.5M | $2.0M | $1.9M | $2.2M | $2.1M | $2.8M | $3.0M |
| Diluted EPS | $0.20 | $0.16 | $0.22 | $0.21 | $0.26 | $0.25 | $0.32 | $0.35 |
| Operating cash flow | $4.5M | $2.3M | $3.2M | $2.1M | $3.9M | $169,000.00 | $3.0M | $3.5M |
| Free cash flow | $4.5M | $2.3M | $2.9M | $1.9M | $3.7M | -$83,000.00 | $2.4M | $3.3M |
| Gross margin | 76.2% | 78.3% | 77.7% | 78.0% | 78.3% | 78.1% | 78.4% | 78.8% |
| Operating margin | 15.7% | 13.2% | 15.6% | 13.6% | 17.5% | 15.8% | 19.2% | 20.3% |
| Net margin | 12.3% | 10.0% | 12.1% | 12.1% | 12.7% | 12.6% | 14.6% | 16.2% |
Company news
Jul 10, 2026
Jul 6, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Nagel Bradley M.· Chief Financial Officer | Tax withholding | 674 | $42.30 | $28,510.20 | filing |
| 2026-06-08 | Cunniff James L.· CEO and President | Sale | 7,003 | $36.25 | $253,851.75 | filing |
| 2026-06-08 | Cunniff James L.· CEO and President | Option exercise | 9,700 | $17.25 | $167,325.00 | filing |
| 2026-06-08 | Cunniff James L.· CEO and President | Sale | 1,671 | $36.80 | $61,488.62 | filing |
| 2026-06-08 | Cunniff James L.· CEO and President | Sale | 1,026 | $37.77 | $38,755.00 | filing |
| 2026-06-04 | Nagel Bradley M.· Chief Financial Officer | Sale | 11,620 | $36.34 | $422,218.51 | filing |
| 2026-06-04 | Nagel Bradley M.· Chief Financial Officer | Option exercise | 5,267 | $10.71 | $56,409.57 | filing |
| 2026-06-04 | Nagel Bradley M.· Chief Financial Officer | Option exercise | 4,334 | $10.25 | $44,423.50 | filing |
| 2026-06-04 | Nagel Bradley M.· Chief Financial Officer | Sale | 181 | $37.11 | $6,717.63 | filing |
| 2026-05-15 | SKARVAN KATHLEEN | Sale | 19,032 | $35.24 | $670,729.55 | filing |
| 2026-05-15 | SKARVAN KATHLEEN | Sale | 9,256 | $36.26 | $335,604.05 | filing |
| 2026-05-15 | SKARVAN KATHLEEN | Sale | 8,150 | $34.36 | $280,055.19 | filing |
| 2026-05-15 | SKARVAN KATHLEEN | Option exercise | 40,000 | $3.82 | $152,800.00 | filing |
| 2026-05-15 | SKARVAN KATHLEEN | Sale | 3,562 | $37.33 | $132,969.46 | filing |
| 2025-12-01 | Tune Kathleen A | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-01 | Erickson Stan K. | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-01 | Fluet Gregory | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-01 | Galatowitsch Joseph L. | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-01 | SKARVAN KATHLEEN | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-01 | Walsh Andrea M. | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-01 | Summers Andrew | Award | 3,000 | $0.00 | $0.00 | filing |
| 2025-09-11 | Summers Andrew | Sale | 3,153 | $24.42 | $77,000.67 | filing |
| 2025-09-10 | Summers Andrew | Sale | 39,378 | $23.68 | $932,435.60 | filing |
| 2025-09-10 | Summers Andrew | Sale | 16,203 | $25.16 | $407,651.28 | filing |
| 2025-09-10 | Summers Andrew | Sale | 6,576 | $25.94 | $170,609.72 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.